학술논문

Emicizumab prophylaxis for the treatment of people with moderate or mild Hemophilia A without Factor VIII inhibitors: results from the primary analysis of the HAVEN 6 study
Document Type
Article
Source
Hämostaseologie; February 2023, Vol. 43 Issue: 1, Number 1 Supplement 1
Subject
Language
ISSN
07209355; 25675761